BioPorto A/S - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for BioPorto A/S. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

BioPorto A/S. The Group's principal activities develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector. The Group's developments include a test (NGAL) to diagnose and monitor acute kidney damage. The Group operates globally.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report